Log in

NYSE:STE - Steris Stock Price, Forecast & News

$168.51
+1.51 (+0.90 %)
(As of 02/18/2020 06:11 AM ET)
Today's Range
$166.15
Now: $168.51
$168.61
50-Day Range
$150.11
MA: $154.21
$168.51
52-Week Range
$118.18
Now: $168.51
$168.61
Volume404,539 shs
Average Volume590,087 shs
Market Capitalization$14.29 billion
P/E Ratio36.63
Dividend Yield0.88%
Beta0.9
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP85915210
Phone353-1232-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.78 billion
Cash Flow$7.61 per share
Book Value$37.66 per share

Profitability

Net Income$304.05 million

Miscellaneous

Employees12,000
Market Cap$14.29 billion
Next Earnings Date5/11/2020 (Estimated)
OptionableOptionable

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.


Steris (NYSE:STE) Frequently Asked Questions

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris announced a quarterly dividend on Monday, February 10th. Stockholders of record on Tuesday, February 25th will be given a dividend of $0.37 per share on Thursday, March 26th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 0.88%. The ex-dividend date of this dividend is Monday, February 24th. View Steris' Dividend History.

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) released its earnings results on Monday, February, 10th. The medical equipment provider reported $1.45 EPS for the quarter, topping the consensus estimate of $1.42 by $0.03. The medical equipment provider earned $774.30 million during the quarter, compared to the consensus estimate of $748.45 million. Steris had a return on equity of 16.33% and a net margin of 13.21%. The firm's quarterly revenue was up 11.2% on a year-over-year basis. During the same period last year, the firm posted $1.26 EPS. View Steris' Earnings History.

When is Steris' next earnings date?

Steris is scheduled to release their next quarterly earnings announcement on Monday, May 11th 2020. View Earnings Estimates for Steris.

What guidance has Steris issued on next quarter's earnings?

Steris issued an update on its FY 2020 After-Hours earnings guidance on Monday, February, 10th. The company provided EPS guidance of 5.65-5.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.57.

What price target have analysts set for STE?

4 brokers have issued 12 month price objectives for Steris' stock. Their forecasts range from $138.00 to $177.00. On average, they anticipate Steris' stock price to reach $155.00 in the next year. This suggests that the stock has a possible downside of 8.0%. View Analyst Price Targets for Steris.

What is the consensus analysts' recommendation for Steris?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Steris.

Has Steris been receiving favorable news coverage?

Media coverage about STE stock has trended very negative on Tuesday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Steris earned a news impact score of -3.0 on InfoTrie's scale. They also gave news stories about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Steris.

Are investors shorting Steris?

Steris saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 2,030,000 shares, an increase of 42.0% from the January 15th total of 1,430,000 shares. Based on an average daily volume of 698,500 shares, the days-to-cover ratio is presently 2.9 days. Currently, 2.4% of the company's stock are sold short. View Steris' Current Options Chain.

Who are some of Steris' key competitors?

What other stocks do shareholders of Steris own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Mastercard (MA), Gilead Sciences (GILD), AbbVie (ABBV), Mcdonald's (MCD), Pfizer (PFE), Stryker (SYK), Abbott Laboratories (ABT), Allergan (AGN) and AT&T (T).

Who are Steris' key executives?

Steris' management team includes the folowing people:
  • Mr. Walter M. Rosebrough Jr., CEO & Pres (Age 65)
  • Mr. Michael J. Tokich, Sr. VP, CFO & Director (Age 50)
  • Mr. Daniel A. Carestio, Chief Operating Officer (Age 46)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. & Director (Age 52)
  • Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 49)

Who are Steris' major shareholders?

Steris' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (4.23%), WCM Investment Management LLC (2.76%), Massachusetts Financial Services Co. MA (2.30%), William Blair Investment Management LLC (1.26%), Goldman Sachs Group Inc. (1.24%) and FMR LLC (1.23%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for Steris.

Which institutional investors are selling Steris stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Great West Life Assurance Co. Can, Principal Financial Group Inc., WCM Investment Management LLC, Bank of New York Mellon Corp, Renaissance Technologies LLC, American International Group Inc., FMR LLC and First Trust Advisors LP. Company insiders that have sold Steris company stock in the last year include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves and Walter M Rosebrough Jr. View Insider Buying and Selling for Steris.

Which institutional investors are buying Steris stock?

STE stock was bought by a variety of institutional investors in the last quarter, including Pictet Asset Management Ltd., State Street Corp, Goldman Sachs Group Inc., Massachusetts Financial Services Co. MA, Franklin Resources Inc., Charles Schwab Investment Management Inc., ArrowMark Colorado Holdings LLC and Barclays PLC. View Insider Buying and Selling for Steris.

How do I buy shares of Steris?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Steris' stock price today?

One share of STE stock can currently be purchased for approximately $168.51.

How big of a company is Steris?

Steris has a market capitalization of $14.29 billion and generates $2.78 billion in revenue each year. The medical equipment provider earns $304.05 million in net income (profit) each year or $4.89 on an earnings per share basis. Steris employs 12,000 workers across the globe.View Additional Information About Steris.

What is Steris' official website?

The official website for Steris is http://www.steris.com/.

How can I contact Steris?

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]


MarketBeat Community Rating for Steris (NYSE STE)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  263 (Vote Outperform)
Underperform Votes:  370 (Vote Underperform)
Total Votes:  633
MarketBeat's community ratings are surveys of what our community members think about Steris and other stocks. Vote "Outperform" if you believe STE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: Diluted Earnings Per Share

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel